抗组胺药在变应性鼻炎中的作用机制及应用进展
作者:

Progress in the mechanism and application of antihistamines in allergic rhinitis
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    变应性鼻炎(AR)是一种鼻黏膜的慢性非感染性炎症,主要是由机体接触致敏变应原后诱发的由特异性免疫球蛋白E(IgE)介导的、多种炎性细胞(如肥大细胞、嗜碱性粒细胞等)参与的鼻黏膜的高敏反应。组胺在AR发病中发挥重要作用,是引起鼻痒、喷嚏、流涕等临床症状的核心介质。抗组胺药物通常通过拮抗组胺相关受体来阻断组胺与受体结合,从而影响变态反应发生的过程。因此,抗组胺药在AR治疗中的应用也越来越重要而广泛。本文主要就抗组胺药在AR中的作用机制及治疗进展作一综述,探讨其在AR的应用价值。

    Abstract:

    Allergic rhinitis (AR) is a chronic non-infectious inflammation of the nasal mucosa. AR is a hypersensitive reaction of nasal mucosa mediated by specific immunoglobulin E (IgE) and involving a variety of inflammatory cells (such as mast cells and basophils, etc.) induced by the body's exposure to allergens. Histamine plays an important role in the pathogenesis of AR, which is the core mediator of clinical symptoms such as nasal itching, sneezing, and runny nose. Antihistamine drugs usually block histamine binding to histamine-associated receptors by antagonizing them, thus affecting the process of allergy. Therefore, the application of antihistamines in AR treatment is becoming more and more important and widespread. This article mainly reviewed the mechanism and treatment progress of antihistamines in AR, and discussed its application value in AR.

    网友评论
    网友评论
    分享到微博
    发 布
    参考文献
    [1] Meltzer EO.Allergic rhinitis:burden of illness,quality of life, comorbidities,and control[J].Immunol Allergy Clin North Am,2016,36(2):235-248.
    [2] Stuck BA,Czajkowski J, Hagner AE, et al.Changes in daytime sleepiness, quality of life,and objective sleep patterns in seasonal allergic rhinitis:a controlled clinical trial[J].Allergy Clin Immunol,2004,113(4):663-668.
    [3] Yanai K,Zhang D,Tashiro M,et al.Positron emission tomography evaluation of sedative properties of antihistamines[J].Expert Opin Drug Saf,2011, 10(4):613-622.
    [4] Panula P,Chazot P. L,Cowart M,et al.International union of basic and clinical pharmacology.XCVIII.Histamine receptors[J].Pharmacol Rev,2015, 67(3):601-655.
    [5] Simons FE.Advances in H1-antihistamines[J].N Engl J Med,2004,351(21):2203-2217.
    [6] Schaefer U, Schmitz V, Schneider,et al. Histamine induced homologous and heterologous regulation of histamine receptor subtype mRNA expression in cultured endothelial cells[J].Shock,1999, 12(4):309-315.
    [7] Feuerstein TJ.Presynaptic receptors for dopamine,histamine,and serotonin[J]. Handb Exp Pharmacol,2008,(184),289-338.
    [8] Aquino-Miranda G, Osorio-Espinoza A, Escamilla-Sánchez J, et al.Histamine H3 receptors modulate depolarization-evoked[3H]-noradrenaline release from rat olfactory bulb slices[J].Neuropharmacology,2012,62(2):1127-1133.
    [9] Cowden JM, Zhang M,Dunford PJ,et al.The histamine H4 receptor mediates inflflammation and pruritus in Th2-dependent dermal inflflammation[J].J Invest Dermatol,2010,130(4):1023-1033.
    [10] Buckland KF, Williams TJ, Conroy DM. Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor[J].Br J Pharmacol,2003,140(6):1117-1127.
    [11] Shiraishi Y,Jia Y,Domenico J,et al.Sequential engagement of FcepsilonRI on mast cells and basophil histamine H(4)receptor and FcepsilonRI in allergic rhinitis[J]. J Immunol,2013,190(5):539-548.
    [12] 杨玉成,张楠,Claus Bachert.新型抗组胺药物治疗变应性鼻炎[J].中国医学文摘耳鼻咽喉科学,2011,26(5):258-259.
    [13] 汪建,彭华.新2代抗组胺药物在变应性鼻炎中的应用[J].中国医学文摘耳鼻咽喉科学, 2013,28(2):80-82.
    [14] Kawauchi H,Yanai K,Wang DY,et al. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties[J].Int J Mol Sci,2019,20(1):213.
    [15] 朱鲁平,程雷.H1抗组胺药的临床药理及其对变应性鼻炎的治疗价值[J].中国中西医结合耳鼻咽喉科杂志,2009,17(1):51-54.
    [16] 李华斌,王向东,王洪田,等.口服H1抗组胺药治疗变应性鼻炎广州共识(2020精要版)[J].中国眼耳鼻喉科杂志,2020,20(2):146-148.
    [17] 程雷.抗组胺药治疗变应性鼻炎[J].中国医学文摘耳鼻咽喉科学,2011,26(5):233-234.
    [18] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科分会鼻科学组.变应性鼻炎诊断和治疗指南(2015年,天津)[J].中华耳鼻咽喉头颈外科杂志,2016,51(1):6-24.
    [19] Carr W, Bernstein J, Lieberman P, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis[J].J Allergy Clin Immunol,2012,129(5):1282-1289.
    [20] Kaliner MA, Storms W, Tilles S, et al.Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis[J].Allergy Asthma Proc,2009,30(3):255-262.
    [21] Greiner AN, Meltzer EO.Overview of the treatment of allergic rhinitis and nonal-lergic rhinopathy[J].Proc Am Thorac Soc,2011, 8(1):121-131.
    [22] Lieberman P.The role of antihistamines in the treatment of vasomotor rhinitis[J]. World Allergy Organ J,2009,2(8):156-161.
    [23] Bernstein JA.Azelastine hydrochloride:a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability[J].Curr Med Res Opin,2007,23(10):2441-2452.
    [24] Taylor-Clark T, Sodha R, Warner B, et al. Histamine receptors that influence blockage of the normal human nasal airway[J].Br J Pharmacol, 2005,144(6):867-874.
    [25] Lee TA,Pickard AS.Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis[J].Pharmacotherapy,2007,27(6):852-859.
    [26] Chipps BE,Harder JM.Antihistamine treatment for allergic rhinitis:different routes,different outcomes?[J].Allergy Asthma Proc,2009,30(6):584-594.
    引证文献
引用本文

吴云姣,杨花荣.抗组胺药在变应性鼻炎中的作用机制及应用进展[J].中国耳鼻咽喉颅底外科杂志,2021,27(6):742-745

复制
分享
文章指标
  • 点击次数:634
  • 下载次数: 756
历史
  • 收稿日期:2021-04-16
  • 在线发布日期: 2022-01-06
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭